Talbot George Harrison 4
4 · Nabriva Therapeutics plc · Filed Sep 29, 2017
Insider Transaction Report
Form 4
Talbot George Harrison
Director
Transactions
- Exercise/Conversion
Stock Option
2017-09-27−1,350→ 0 totalExp: 2017-09-27→ Ordinary Shares (1,350 underlying) - Exercise/Conversion
Ordinary Shares
2017-09-27+1,350→ 33,140 total
Footnotes (3)
- [F1]Dr. Talbot exercised his remaining stock options under the Company's Stock Option Plan 2007, which were set to expire on September 27, 2017. Dr. Talbot paid the exercise price in cash.
- [F2]The exercise price was .672 euros per share.
- [F3]These options were granted on various dates between 2009 and 2014 and are fully vested.